Coegin Pharma AB

Coegin Pharma AB is a Aktiebolag in LUND, Sweden with 3 ISIN-identified securities mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 8 years, since 16 Nov 2017. That is about 2 years earlier than the median LEI in Sweden, which dates from 2020 — an early adopter by local standards.

The next annual re-validation is due 12 Dec 2027, 398 days from now.

This archive holds 2 versions of the record. The most recent change was on 17 Oct 2026 and altered the legal address, city, hq address, next renewal; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.

The entity is registered with Companies Register under registry number 559078-0465, and the LEI itself is issued and maintained by Ubisecure Oy, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 3 ISINs are mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.